Based on our experience, it’s a claim we can make with 100% certainty. Since 2019, when ProxsysRx launched its 340B Support Services division, we’ve managed the 340B programs of 18 health systems. Altogether, we’ve generated more than $500 million in 340B Savings and Revenue for those health systems — $98M in the first 10 months … Read More
Uncategorized
340B ESP ‘Terms Of Use’ Set The Tone For The Spurious Demands It Places On Covered Entities.
What does it mean for covered entities already desperate for diminishing 340B savings and revenue? As we noted in a previous post, 340B ESP is nothing less than a brazen and (in our opinion) unlawful ploy by the drug manufacturers to evade the discounts they are legally obligated to offer eligible entities — by placing … Read More
340B ESP. Why It’s Wrong, And How Hospitals Can Deal With It.
(NOTE: Over the years, we’ve served dozens of non-profit hospitals. We’ve seen the profound impact the 340B program has had in supporting their missions of serving the most vulnerable members of their communities. That said, we apologize, in advance, for the stridency of our tone on this page — but not for our sense of … Read More
Seven Steps For Overcoming 340B ESP and Other Manufacturer Restrictions on 340B Pricing
Since 2019, ProxsysRx’s 340B team has generated over $500 million in 340B revenue for the health systems we serve. During that time, we’ve developed any number of strategies and tactics for overcoming 340B ESP and other manufacturer restrictions. Below are the seven key elements of our process. 1. Establishing communications between health system providers and … Read More
Enhancing Patient Care and System Revenue: The Case for Onsite Specialty Pharmacies in 340B Hospitals.
As chronic illnesses become increasingly common in the United States, the number of specialty medications for managing these conditions has skyrocketed. From a financial perspective, the number one reason a 340B hospital should consider an onsite specialty pharmacy is the significantly increased potential for generating 340B savings — and for passing-along those savings to patients … Read More
Starting A 340B Specialty Pharmacy: What Does The Process Look Like?
Opening an onsite specialty pharmacy is extremely challenging — particularly given the effort required just to get access to purchase specialty meds, and then to get “In Network” with PBMs. That said, ProxsysRx has developed a proven process for meeting those challenges. Owning a successful specialty pharmacy starts with optimizing your 340B program (For an … Read More
How Can Your 340B Hospital Pay For Its Own Specialty Pharmacy?
Since 2019, ProxsysRx has generated more than $500 million in 340B savings and revenue for the health systems we serve — and yes, we’ve learned to overcome many of even the toughest manufacturers restrictions. We work with hospitals to unlock pharmacy’s potential throughout the continuum of care. We optimize revenues from their 340B programs and … Read More
Best Practices For A Successful 340B Specialty Pharmacy
Below are highlights of an in-depth roundtable discussion outlining how eligible health systems can ensure the success of their onsite specialty pharmacies. To watch videos of that discussion, organized by topic, Click Here. You can also find a curated transcript of the entire discussion here. Nurture strong pharmacist / provider relationships It’s critical that you … Read More